SecSonar.com

Stryker Corporation (SYK)

Stryker Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Stryker Corporation (SYK) is a Medical - Devices company based in US with a market capitalization of $118.1B. Revenue grew 11.2% year-over-year and the company generated $4.3B in free cash flow. This page tracks SYK's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 53K employees · IPO Mar 17, 1980

Valuation

Valuation & price

$299.77 · as of May 13, 2026 · -25.7% vs 52w high

35.3

P/E ratio

Latest-FY diluted EPS

5.27

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$404$345$285Jul 25Dec 25Jun 26Jul 7, 25$392.51Jul 9, 25$392.05Jul 11, 25$389.46Jul 15, 25$390.59Jul 17, 25$388.90Jul 21, 25$387.32Jul 23, 25$400.93Jul 25, 25$403.53Jul 29, 25$400.57Jul 31, 25$392.73Aug 4, 25$381.49Aug 6, 25$374.94Aug 8, 25$377.58Aug 12, 25$376.61Aug 14, 25$378.52Aug 18, 25$381.61Aug 20, 25$391.87Aug 22, 25$394.22Aug 27, 25$393.15Aug 29, 25$391.41Sep 3, 25$388.56Sep 5, 25$392.31Sep 9, 25$392.76Sep 11, 25$388.79Sep 15, 25$377.11Sep 17, 25$376.88Sep 19, 25$376.83Sep 23, 25$373.52Sep 25, 25$368.57Sep 29, 25$369.88Oct 1, 25$364.15Oct 3, 25$370.50Oct 7, 25$369.24Oct 9, 25$370.20Oct 13, 25$364.92Oct 16, 25$369.25Oct 20, 25$381.22Oct 22, 25$388.35Oct 24, 25$381.79Oct 28, 25$375.93Oct 30, 25$368.98Nov 3, 25$358.16Nov 5, 25$357.67Nov 7, 25$356.03Nov 11, 25$363.70Nov 13, 25$373.42Nov 17, 25$360.13Nov 19, 25$364.23Nov 21, 25$368.27Nov 25, 25$375.08Nov 28, 25$371.18Dec 2, 25$366.68Dec 5, 25$364.02Dec 9, 25$349.23Dec 11, 25$352.97Dec 15, 25$355.31Dec 17, 25$352.58Dec 19, 25$355.20Dec 23, 25$354.82Dec 26, 25$354.22Dec 30, 25$354.17Jan 2, 26$348.18Jan 6, 26$366.39Jan 8, 26$367.21Jan 12, 26$361.37Jan 14, 26$359.39Jan 16, 26$363.78Jan 21, 26$362.94Jan 23, 26$355.04Jan 28, 26$357.83Jan 30, 26$369.56Feb 3, 26$360.82Feb 5, 26$362.42Feb 9, 26$356.08Feb 11, 26$363.70Feb 13, 26$366.05Feb 18, 26$377.32Feb 20, 26$380.23Feb 24, 26$381.33Feb 26, 26$386.06Mar 2, 26$387.02Mar 4, 26$381.89Mar 6, 26$364.56Mar 10, 26$358.65Mar 12, 26$337.21Mar 16, 26$349.56Mar 19, 26$339.76Mar 23, 26$332.59Mar 25, 26$327.65Mar 27, 26$327.44Mar 31, 26$328.59Apr 2, 26$331.54Apr 7, 26$332.07Apr 9, 26$339.14Apr 13, 26$347.24Apr 15, 26$341.24Apr 17, 26$343.32Apr 21, 26$327.30Apr 23, 26$329.65Apr 27, 26$329.01Apr 29, 26$315.13May 1, 26$294.73May 5, 26$295.25May 8, 26$285.47May 12, 26$294.45May 14, 26$305.51May 18, 26$313.22May 20, 26$321.49May 22, 26$316.48May 27, 26$305.94May 29, 26$305.09Jun 2, 26$293.30Jun 4, 26$301.21Jun 8, 26$301.53Jun 10, 26$308.84Jun 12, 26$312.20Jun 16, 26$310.58Jun 18, 26$307.80Jun 23, 26$310.00Jun 29, 26$333.26
$282.5852-week range$403.53
Loading valuation history…

Fundamentals

Key fundamentals

$118.1B

Market cap

11.2%

Revenue growth (YoY)

64.0%

Gross margin

$4.3B

Free cash flow (USD)

$10.8B

Net debt

0.3%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$11.3BFY 2017$12.4BFY 2018$13.6BFY 2019$14.9BFY 2020$14.4BFY 2021$17.1BFY 2022$18.4BFY 2023$20.5BFY 2024$22.6BFY 2025$25.1B
$11.3B$25.1B

Free cash flow by year

2016 → 2025

FY 2016$1.4BFY 2017$961.0MFY 2018$2.0BFY 2019$1.5BFY 2020$2.8BFY 2021$2.7BFY 2022$2.0BFY 2023$3.1BFY 2024$3.5BFY 2025$4.3B
$1.4B$4.3B

Gross margin by year

2021 → 2025

FY 202162.6%FY 202259.8%FY 202361.0%FY 202461.9%FY 202564.0%
62.6%64.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 11, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventOrganizational RestructuringJun 26, 2026Filing
  • 8-K eventExecutive Officer ChangesMay 20, 2026Filing
  • Quarterly report10-Q FiledMay 11, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 8, 2026Filing
  • 8-K eventEarnings ReleaseApr 30, 2026Filing
  • 8-K eventCybersecurity Incident UpdateApr 9, 2026Filing

Questions

Frequently asked questions

What is Stryker Corporation's market cap?

Stryker Corporation (SYK) has a market capitalization of $118.1B.

What is SYK's P/E ratio?

SYK trades at a price-to-earnings ratio of 35.3, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is SYK's price-to-book (P/B) ratio?

SYK trades at 5.27 times book value per share.

Are insiders buying SYK stock?

SEC Form 4 filings show no open-market insider buys at Stryker Corporation in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

MDT

Medtronic plc

$95.6B

ABT

Abbott Laboratories

$149.4B

ISRG

Intuitive Surgical, Inc.

$149.6B

BSX

Boston Scientific Corporation

$71.7B

EW

Edwards Lifesciences Corporation

$49.6B

DXCM

DexCom, Inc.

$28.4B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.